| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Pathogénie Microbienne Moléculaire Unit, Institut National de la Santé et de la Recherche Médicale U389,
DNA Chip Platform, Genopole, and
Imunité Innée et Signalisation, Pasteur Institute, Paris, France; and
Danone Vitapole, Nutrivaleur, Palaiseau, France
Shigella invades the human intestinal mucosa, thus causing bacillary dysentery, an acute recto-colitis responsible for lethal complications, mostly in infants and toddlers. Conversely, commensal bacteria live in a mutualistic relationship with the intestinal mucosa that is characterized by homeostatic control of innate responses, thereby contributing to tolerance to the flora. Cross-talk established between commensals and the intestinal epithelium mediate this active process, the mechanisms of which remain largely uncharacterized. Probiotics such as Lactobacillus casei belong to a subclass of these commensals that modulate mucosal innate responses and possibly display anti-inflammatory properties. We analyzed whether L. casei could attenuate the pro-inflammatory signaling induced by Shigella flexneri after invasion of the epithelial lining. Cultured epithelial cells were infected with L. casei, followed by a challenge with S. flexneri. Using macroarray DNA chips, we observed that L. casei down-regulated the transcription of a number of genes encoding pro-inflammatory effectors such as cytokines and chemokines and adherence molecules induced by invasive S. flexneri. This resulted in an anti-inflammatory effect that appeared mediated by the inhibition of the NF-
B pathway, particularly through stabilization of I-B
. In a time-course experiment using GeneChip hybridization analysis, the expression of many genes involved in ubiquitination and proteasome processes were modulated during L. casei treatment. Thus, L. casei has developed a sophisticated means to maintain intestinal homeostasis through a process that involves manipulation of the ubiquitin/proteasome pathway upstream of I-B.
This article has been cited by other articles:
|
|
 |
|
  T. Watanabe, H. Nishio, T. Tanigawa, H. Yamagami, H. Okazaki, K. Watanabe, K. Tominaga, Y. Fujiwara, N. Oshitani, T. Asahara, et al. Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid Am J Physiol Gastrointest Liver Physiol, September 1, 2009; 297(3): G506 - G513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Jandu, Z. J. Zeng, K. C. Johnson-Henry, and P. M. Sherman Probiotics prevent enterohaemorrhagic Escherichia coli O157 : H7-mediated inhibition of interferon-{gamma}-induced tyrosine phosphorylation of STAT-1 Microbiology, February 1, 2009; 155(2): 531 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cosseau, D. A. Devine, E. Dullaghan, J. L. Gardy, A. Chikatamarla, S. Gellatly, L. L. Yu, J. Pistolic, R. Falsafi, J. Tagg, et al. The Commensal Streptococcus salivarius K12 Downregulates the Innate Immune Responses of Human Epithelial Cells and Promotes Host-Microbe Homeostasis Infect. Immun., September 1, 2008; 76(9): 4163 - 4175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Hamon, E. Batsche, B. Regnault, T. N. Tham, S. Seveau, C. Muchardt, and P. Cossart Histone modifications induced by a family of bacterial toxins PNAS, August 14, 2007; 104(33): 13467 - 13472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yin and B. A. Dale Activation of protective responses in oral epithelial cells by Fusobacterium nucleatum and human {beta}-defensin-2 J. Med. Microbiol., July 1, 2007; 56(7): 976 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Chichlowski, J. Croom, B. W. McBride, L. Daniel, G. Davis, and M. D. Koci Direct-Fed Microbial PrimaLac and Salinomycin Modulate Whole-Body and Intestinal Oxygen Consumption and Intestinal Mucosal Cytokine Production in the Broiler Chick Poult. Sci., June 1, 2007; 86(6): 1100 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Corthesy, H. R. Gaskins, and A. Mercenier Cross-Talk between Probiotic Bacteria and the Host Immune System J. Nutr., March 1, 2007; 137(3): 781S - 790S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fillon, K. Soulis, S. Rajasekaran, H. Benedict-Hamilton, J. N. Radin, C. J. Orihuela, K. C. El Kasmi, G. Murti, D. Kaushal, M. W. Gaber, et al. Platelet-Activating Factor Receptor and Innate Immunity: Uptake of Gram-Positive Bacterial Cell Wall into Host Cells and Cell-Specific Pathophysiology J. Immunol., November 1, 2006; 177(9): 6182 - 6191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vojdani and J. Erde Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Allergic and Infectious Disease Pathology (II) Evid. Based Complement. Altern. Med., June 1, 2006; 3(2): 209 - 215. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
